vTv Therapeutics Inc. (VTVT)
Data as of , from SEC Form 4 filings.
See up to 3 months of VTVT. The 7-day demo opens the 1M and 3M ranges and puts VTVT on your watchlist.
Start 7-day demoLatest VTVT insider trades
About vTv Therapeutics Inc. (VTVT)
vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.
- HIGH POINT, NC
- 26
- 2015
- XNAS
https://www.vtvtherapeutics.comSEC filings for VTVT on EDGAR
VTVT Form 4 activity by transaction type, last 90 days
No Form 4 activity for VTVT in the last 90 days.
VTVT insider transactions (Form 4)
3217 Form 4 filings on record, the earliest from Nov 19, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | Grant or award | Non-Qualified Stock Option (right to buy) | 6,000 footnote F1 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non-Qualified Stock Option (right to buy) | 6,000 footnote F1 | $0.00 | - | |
| ||||||
| Daniel K. Spiegelman - Director | Grant or award | Director stock option (right to buy) | 6,000 | $35.08 | $210K | |
 Srinivas Akkaraju - Director | Grant or award | Director stock option (right to buy) | 6,000 | $35.08 | $210K | |
| Fahed Al-Marzooqi - Director | Grant or award | Director stock option (right to buy) | 6,000 | $35.08 | $210K | |
| Anne M. Phillips - Director | Grant or award | Director stock option (right to buy) | 6,000 | $35.08 | $210K | |
| Michael Stephen Tung - Officer | Grant or award | Employee stock option (right to buy) | 44,969 | $36.92 | $1.66M | |
| Paul J. Sekhri - Officer | Grant or award | Class A Common Stock | 140,000 | $36.92 | $5.17M | |
| Srinivas Akkaraju | Grant or award | Class A Common Stock | 106,000 | $15.27 | $1.62M | |
| Srinivas Akkaraju | Grant or award | Pre-Funded Warrants (Right to Buy) | 877,214 | - | - | |
| Srinivas Akkaraju | Grant or award | Warrant (Right to Buy) | 983,214 | - | - | |
| Srinivas Akkaraju | Grant or award | Pre-Funded Warrants (Right to Buy) | 655,523 | - | - | |
| Srinivas Akkaraju | Grant or award | Warrant to Purchase Class A Common Stock (Right to Buy) | 655,523 | - | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Common Stock | 4,308 | - | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Common Stock | 46,692 | - | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Prefunded Warrants | 217,144 | - | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Prefunded Warrants | 2,353,913 | - | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Common Warrant | 221,452 | - | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Common Warrant | 2,400,605 | - | - | |
| Srinivas Akkaraju - Director | Grant or award | Director stock option (right to buy) | 4,000 | $16.59 | $66K | |
| Daniel K. Spiegelman - Director | Grant or award | Director stock option (right to buy) | 4,000 | $16.59 | $66K | |
| BAKER BROS. ADVISORS LP | Grant or award | Non- Qualified Stock Option (right to buy) | 4,000 | $0.00 | - | |
| BAKER BROS. ADVISORS LP | Grant or award | Non- Qualified Stock Option (right to buy) | 4,000 | $0.00 | - | |
| Srinivas Akkaraju - Director | Grant or award | Director stock option (right to buy) | 2,250 | $17.22 | $39K | |
| Srinivas Akkaraju - Director | Grant or award | Director stock option (right to buy) | 983 | $17.22 | $17K | |
| Samsara BioCapital GP, LLC | Other | Class A Common Stock | 58,836 | - | - | |
| Samsara BioCapital GP, LLC | Grant or award | Pre- Funded Warrants (Right to Buy) | 58,885 | - | - | |
| Srinivas Akkaraju | Derivative | Class A Common Stock | 58,836 | - | - | |
| Srinivas Akkaraju | Grant or award | Pre- Funded Warrants (Right to Buy) | 58,885 | - | - | |
| Paul J. Sekhri - Officer | Open-market purchase | Class A Common Stock | 1,378 | $16.35 | $23K | |
| Paul J. Sekhri - Officer | Open-market purchase | Class A Common Stock | 1,778 | $16.88 | $30K | |
| Paul J. Sekhri - Officer | Open-market purchase | Class A Common Stock | 1,844 | $16.96 | $31K | |
VTVT insider trading FAQ
What is the latest insider trade for VTVT?
vTv Therapeutics Inc. (VTVT) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-29. The full record for VTVT runs to 17 Form 4 filings, the earliest from 2024-11-19. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VTVT stock?
No insider purchases of VTVT were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling VTVT stock?
No insider sales of VTVT were filed in the last 90 days.
Where can I see VTVT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VTVT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - BAKER BROS. ADVISORS LP view on EDGAR
- - Daniel K. Spiegelman view on EDGAR
- - Srinivas Akkaraju view on EDGAR
- - Fahed Al-Marzooqi view on EDGAR
- - Anne M. Phillips view on EDGAR
- - Michael Stephen Tung view on EDGAR
- - Paul J. Sekhri view on EDGAR
- - Srinivas Akkaraju view on EDGAR
- - Srinivas Akkaraju view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where VTVT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VTVT with a 7-day demo
- VTVT on your watchlist
- Every VTVT Form 4 filing on record
- Up to 3 months of VTVT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
